Skip to main content
. 1999 Mar;6(2):186–192. doi: 10.1128/cdli.6.2.186-192.1999

FIG. 5.

FIG. 5

Protection against mortality due to influenza virus infection in mice administered B. breve YIT4064 orally. Oral immunization and nasal inoculation in each group were performed in the same manner as described in the legend to Fig. 4. After nasal injection of PR8, the mice were observed for survival for 14 to 21 days. Created by potrace 1.16, written by Peter Selinger 2001-2019 , P < 0.05 versus survival rate in group 7 or 9, by Fisher’s exact test.